CALML5 and Alzheimer disease: CLSPCOL penetrates the blood-brain barrier efficiently (Fig. 5b) and has potent AD-suppressing activity (Supplementary Figs. 19 and 20) that is free from the inhibition by the CLSP inhibitors (Supplementary Fig. 16).